A recent study analyzing data from over 10 million patients indicates that legal access to cannabis significantly reduces the prescription rates for anxiolytics like benzodiazepines.
The findings reveal that in states legalizing medical cannabis, benzodiazepine prescriptions have decreased by 12.4%, with a 15.2% decrease in states where recreational cannabis is legalized.
This suggests that cannabis acts as a sort of 'over the counter' alternative for individuals seeking relief, potentially leading them to avoid traditional prescriptions.
The reduction in anxiolytic prescriptions due to cannabis legalization illustrates the profound influence of cannabis on healthcare, particularly in managing mental health.
[
Collection
]
[
|
...
]